Reversible ischemic neurologic deficit after ECT

Journal of ECT

Volumn 14, Issue 1, 1998, Pages 42-48

  Miller, Anthony R ^a   Isenberg, Keith E ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry ^*  (United States)

Author keywords

Ancrod; Cerebrovascular disorders; Depressive disorders; Electroconvulsive therapy; Reversible ischemic neurologic deficit (RIND)

Indexed keywords

CAFFEINE; CLONAZEPAM; CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; NEFAZODONE; OMEPRAZOLE;

ADULT; APHASIA; ARTICLE; BRAIN ISCHEMIA; CASE REPORT; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; FEMALE; HEMIPARESIS; HUMAN; HYPERTENSION; NEUROLOGIC DISEASE; PSYCHOTHERAPY; VISUAL FIELD DEFECT;

EID: 0031834012     PISSN: 10950680     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124509-199803000-00007     Document Type: Article

References (44)

1. Acevedo AG, Smith JK. Adverse reaction to use of caffeine in ECT [Letter]. Am J Psychiatry 1988;145:529-30.
2. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. Circulation 1994;90:1588-601.
3. Adams RJ. Management issues for patients with ischemic stroke. Neurology 1995;45(suppl 1):S15-8.
4. Alberts MJ, Lyden PD, Zivin JA, et al. Emergency brain resuscitation (position paper). Ann Intern Med 1995;122:622-7.
5. Ancrod Stroke Study Investigators. Ancrod for the treatment of acute ischemic brain infarction. Stroke 1994;25:1755-9.
6. Coffey CE, Figiel GS, Weiner RD, Saunders WB. Caffeine augmentation of ECT. Am J Psychiatry 1990,147:579-84.
7. Dehne TL. Symposium: complications and contraindications to electroshock therapy. Arch Neurol Psychiatry 1943;49:786.
8. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does ECT alter brain structure? Am J Psychiatry 1994;151:957-70.
9. Eyman EV, Morris HH. Deaths associated with electric shock therapy. Arch Neural Psychiatry 1950;64:263.
10. Eyres AE. A resume of six fatalities in electric shock treatment. Conf Neurol 1956;16:149. (Cited in Impastato, 1957).
11. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993;153:1201-9.
12. Frederiksen SO, d'Elia G. Electroconvulsive therapy in Sweden. Br J Psychiatry 1979;134:283-7.
13. Heshe J, Roeder E. Electroconvulsive therapy in Denmark. Br J Psychiatry 1976;128:241-5.
14. Impastato DJ. Prevention of fatalities in electroshock therapy. Dis Nerv Syst 1957,18:34-75.
15. Jaffe R, Brubaker G, Dubin WR, Roemer R. Caffeine-associated cardiac dysrhythmia during ECT: report of three cases. Convulsive Ther 1990;6:308-13.
16. Kaldeck R. Transient hemiplegia following electroconvulsive treatment. Arch Neurol Psychiatry 1948;59:229-32.
17. Knapp RB, Topkins MJ, Artusio JF. The cerebrovascular accident and coronary occlusion in anesthesia. JAMA 1962;182:332-4.
18. Landercasper J, Merz BJ, Cogbill TH, et al. Perioperative stroke risk in 173 consecutive patients with a past history of stroke. Arch Surg 1990;125:986-9.
19. Larsen EF, Vraa-Jensen G. Ischemic changes in the brain following electroshock therapy. Acta Psychiatr Neurol Scand 1953;28:75-80.
20. Larsen SF, Zaric D, Boysen G. Postoperative cerebrovascular accidents in general surgery. Acta Anaesthesiol Scand 1988;32:698-701.
21. Liban E, Halpern L, Rozanski J. Vascular changes in the brain in a fatality following electroshock. J Neuropathol Exp Neurol 1951;10:309-18
22. Lishman WA. Organic psychiatry: the psychological consequences of cerebral disorder. 2nd ed. Oxford: Blackwell Scientific Publications, 1987:258.
23. Maclay WS. Death due to treatment: President's address. Proc R Soc Med 1953;46:13-20.
24. Marchand L, Massen J. Un cas de mort par electroshock. Ann Med Psychol 1947;105:556-60. (Cited in Impastato. 1957).
25. Marier TR, Brott T, Broderick J, et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
26. Martin PH. Convulsive therapies: review of 511 cases at Pontiac State Hospital. J Nerv Ment Disord 1949;109:142-57.
27. Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull 1992;48:276-308.
28. Medlicott RW. Convulsive therapy: results and complications in 400 cases. N Z Med J 1948;47:338. (Cited in Impastato, 1957).
29. Meyer A, Teare D. Cerebral fat embolism after electrical convulsion. Br Med J 1945;2:45-6.
30. Napier FJ. Death from electrical convulsion therapy. J Ment Sci 1944;90:875-8.
31. Olsen CW. An unusual reaction to electroshock treatment: unilateral convulsion and transient hemiplegia. Bull Los Angeles Neural Soc 1944;9:171. (Cited in Kaldeck, 1948).
32. Paganini-Hill A, Ross RK, Henderson BE, Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 1988;297:519-22.
33. Physicians' Desk Reference. Montvale, NJ: Medical Economics Company, 1997:776-9.
34. Pincus JH, Tucker GJ. Behavioral neurology. 3rd edition. New York: Oxford University Press, 1985:15,43.
35. Raskin N, Johnson RS. An electric shock casualty. Dis Nerv Syst 1951;12:373-5.
36. Riese W, Fultz GS. Electrical shock treatment succeeded by complete flaccid paralysis, hallucinations, and sudden death. Am J Psychiatry 1949;106:206-13.
37. Ropper AH, Wechsler LR, Wilson LS. Carotid bruit and the risk of stroke in elective surgery. N Engl J Med 1982;307:1388-90.
38. Sacco RL. Vascular disease. In: Rowland LP, ed. Merritt's textbook of neurology. Baltimore: Williams & Wilkins, 1995:227.
39. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839-46.
40. Soutar RL, Ginsberg JS. Anticoagulant therapy with ancrod. Crit Rev Oncol Hematol 1993;15:23-33.
41. Strain JJ, Bidder TG. Transient cerebral complication associated with multiple monitored electroconvulsive therapy. Dis Nerv Syst 1971;32:95-100.
42. Turek IS, Hanlon TE. The effectiveness and safety of electroconvulsive therapy. J Nerv Ment Dis 1977;164:419-31.
43. Weisberg LA, Elliot D, Mielke D. Intracerebral hemorrhage following electroconvulsive therapy. Neurology 1991;41:1849.
44. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50: the Framingham study. N Engl J Med 1985;313:1038-43.